BioFuse™ is a new RF tissue sealing and welding technology. Using transformative technology which is proven in Europe in 1000’s of cases, this surgical innovation replaces traditional methods of sutures, staples and electrosurgical vessel sealing.
BioFuse Technology:

• Can address a broad range of clinical applications in many disciplines
• Has a robust pipeline of products in various stages of development
• Already has an FDA 510k clearance for vessel sealing, solid IP protection and a vast arsenal of trade secrets

Scott Sanders has led key strategic developments in senior executive positions for more than 21 years at Olympus Corporation and Gyrus ACMI.  He also assisted in the creation and implementation of Olympus’ RF product development, reimbursement strategies and procedure development.  In addition, he launched revolutionary technologies of the PK Generator and instrumentation to the Thunderbeat System, which combines bipolar RF energy with ultrasonics.

(This webinar will be recorded)

NOTE: Registration fields may fail to appear in some browsers which are not up to date or running certain extensions. If registration fields fail to appear on this page, please try cutting and pasting the URL in the address bar at the top of the page into a Chrome browser window or clearing the cache in your existing browser. We apologize for any inconvenience.